Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Ayuk

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 19, 2020
Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for MyelofibrosisIsik Kaygusuz Atagunduz, Maximilian Christopeit, Francis Ayuk, et al.
Haematologica|February 14, 2007
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantationUlrike Mösbauer, Francis Ayuk, Heike Schieder, et al.
Experimental Hematology|May 27, 2006
Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission statusNicolaus Kröger, Tatjana Zabelina, Francis Ayuk, et al.
Oncotarget|August 27, 2016
Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulinsAneta Schieferdecker, Ofer Shoshani, Benedikt Westner, et al.
European Journal of Haematology|October 17, 2023
Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomasRadwan Massoud, Hassan Naim, Evgeny Klyuchnikov, et al.
Frontiers in Oncology|November 30, 2023
Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairmentFranziska Marquard, Claudia Langebrake, Dietlinde Janson, et al.
Advances in Hematology|October 29, 2010
The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma PatientsEvgeny Klyuchnikov, Ulrike Bacher, Nicolaus Kröger, et al.
Transplantation and Cellular Therapy|November 14, 2021
Iron Chelation With Deferasirox Increases Busulfan AUC During Conditioning Chemotherapy Prior to Allogeneic Stem Cell TransplantationSonja Essmann, Adrin Dadkhah, Dietlinde Janson, et al.
European Journal of Haematology|December 19, 2015
Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromesMaximilian Christopeit, Anita Badbaran, Malik Alawi, et al.
Bone Marrow Transplantation|May 25, 2020
Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell levelFranziska Modemann, Francis Ayuk, Christine Wolschke, et al.
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 19, 2020
Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for MyelofibrosisIsik Kaygusuz Atagunduz, Maximilian Christopeit, Francis Ayuk, et al.
Haematologica|February 14, 2007
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantationUlrike Mösbauer, Francis Ayuk, Heike Schieder, et al.
Experimental Hematology|May 27, 2006
Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission statusNicolaus Kröger, Tatjana Zabelina, Francis Ayuk, et al.
Oncotarget|August 27, 2016
Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulinsAneta Schieferdecker, Ofer Shoshani, Benedikt Westner, et al.
European Journal of Haematology|October 17, 2023
Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomasRadwan Massoud, Hassan Naim, Evgeny Klyuchnikov, et al.
Frontiers in Oncology|November 30, 2023
Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairmentFranziska Marquard, Claudia Langebrake, Dietlinde Janson, et al.
Advances in Hematology|October 29, 2010
The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma PatientsEvgeny Klyuchnikov, Ulrike Bacher, Nicolaus Kröger, et al.
Transplantation and Cellular Therapy|November 14, 2021
Iron Chelation With Deferasirox Increases Busulfan AUC During Conditioning Chemotherapy Prior to Allogeneic Stem Cell TransplantationSonja Essmann, Adrin Dadkhah, Dietlinde Janson, et al.
European Journal of Haematology|December 19, 2015
Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with myelodysplastic syndromesMaximilian Christopeit, Anita Badbaran, Malik Alawi, et al.
Bone Marrow Transplantation|May 25, 2020
Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell levelFranziska Modemann, Francis Ayuk, Christine Wolschke, et al.
Pageof 18